NEO NeoGenomics Inc
Company Analysis
Latest News
🔴 NeoGenomics is trading 4.7% down in pre-market amid broader risk-off pressure
NeoGenomics is trading at $15.62, down 4.7%, in pre-market; broader risk-off sentiment may be a factor. - No company-specific announcement explaining the move...
🔴 NeoGenomics is trading 5% down today amid sharp broader-market losses
NeoGenomics is trading 5.25% lower at $16.14 on October 22, 2026, amid broader market weakness, though the precise cause is not established. - No new...
🔴 NeoGenomics is trading 4.03% down amid broad market weakness
NeoGenomics is trading at $16.55, down 4.03%, amid broad market weakness; no clear company-specific announcement explaining the October 16 decline was...
🟢 NeoGenomics is trading 4.2% up with no clear catalyst
NeoGenomics is trading at $16.88, up +4.20%, with the cause of the intraday rise unclear. - No clear company-specific announcement or catalyst for the October...
🔴 NeoGenomics is trading 4.3% down today in pre-market
NeoGenomics is trading at $15.65, down 4.28%, with no clear company-specific catalyst identified for the October 12 pre-market decline. - The October 5...
NeoGenomics Beats on Revenue but Loses Its CEO — Can a Leadership Shake-Up Keep the Growth Story Intact?
Shares of NeoGenomics plunged 11% to $17.02 on October 6, erasing weeks of gains even as broader markets traded higher. The catalyst: a mixed bag delivered...
🔴 NeoGenomics is trading 11% down today as CEO transition news weighed on shares
NeoGenomics is trading 11% down at $17.02 after its CEO succession announcement weighed on sentiment. - In its October 5 announcement, the company reported...
🔴 NeoGenomics is trading 6% down today after CEO succession announcement
NeoGenomics is trading 5.91% lower at $18.00 following the October 5 announcement that Warren Stone will become CEO in January 2027. - Shares fell 3.6% in...
🟢 NeoGenomics is trading 4.11% up in pre-market with broader markets higher
NeoGenomics is trading at $19.92, up 4.11% from its $19.13 previous close; broader-market support is possible, not confirmed. - Nasdaq Composite is up 0.61%;...
🔴 NeoGenomics is trading 4.34% down in after-hours trading; no confirmed direct catalyst found
NeoGenomics is trading 4.34% down at $18.30 in after-hours trading after closing at $19.13 on October 5, 2026; no reliable report directly attributes the...
NeoGenomics reports preliminary third quarter 2026 revenue of $209M and 28% NGS growth
NeoGenomics announced preliminary results for the third quarter of 2026, expecting total revenue of approximately $209 million. The company also unveiled a...
NeoGenomics Names Warren Stone CEO, Reports Preliminary $209 Million Q3 Revenue
NeoGenomics announced a planned leadership transition as part of the Board of Directors’ long-term succession plan. President and Chief Operating Officer...
🟢 NeoGenomics is trading 5% up today, amid broader rally as rate-hike concerns eased
NeoGenomics is trading 4.89% higher at $18.65, likely amid broad risk-on sentiment as rate-hike concerns eased. - September payrolls came in at 29,000, below...
🟢 NeoGenomics is trading 0.7% up in pre-market — catalyst unconfirmed
NeoGenomics is trading 0.7% higher in pre-market at $17.90, versus its October 1 close, with no confirmed company-specific catalyst. - The supplied price...
🟢 NeoGenomics is trading 4.1% up in pre-market
NeoGenomics is trading at $18.51, up 4.1%, with no confirmed catalyst. - Shares rose to $18.59 after hours, but the reason for the move remains unclear. - No...
🟢 NeoGenomics is trading 4.6% up in after-hours trading — reason remains unclear
NeoGenomics is trading at $18.59, up 4.56%, in after-hours trading; the reason for the rise remains unclear. - No clear company-specific announcement...
🟢 NeoGenomics is trading 4.4% up today as healthcare sector gains
NeoGenomics is trading 4.41% higher at $19.17, with the move appearing primarily driven by healthcare-sector strength. - Healthcare rose 1.27% on renewed...
🔴 NeoGenomics is trading at 4.18% down in pre-market with no confirmed company-specific catalyst
NeoGenomics is trading 4.18% lower at $18.10, with no confirmed company-specific announcement or overnight catalyst explaining the decline. - The stock closed...
🟢 NeoGenomics is trading 5% up in after-hours trading with no confirmed catalyst
NeoGenomics is trading 5.44% higher at $19.92 after closing at $18.89 on September 22, 2026; no confirmed company-specific announcement or news explains the...
🟢 NeoGenomics is trading 4.12% up today as major indexes rise
NeoGenomics is trading 4.12% up at $19.72, moving alongside a broader September 17, 2026 equity rally. - The S&P 500, Nasdaq Composite, and Dow Jones...